Home » Topics » Medical technology

Medical technology
RSS

Exelixis, Elan Entering Deal To Make Compound Library

Aug. 15, 2001

Northwest Biotherapeutics Files To Test Public Market

Aug. 15, 2001

Other News To Note

Aug. 15, 2001

Novel Candidate Antigens In E. coli Malaria Vaccine Sees Phase Trials This Year Or Early In 2001

Aug. 15, 2001

Corrections

Aug. 15, 2001

ICOS Joins Array BioPharma, Seattle Genetics In Two Deals

Aug. 15, 2001

Conflicting Reactions To EU¿s GMO Authorization Proposals

Aug. 15, 2001

Hemosol Nosedives After FDA Asks Phase III Trial Changes

Aug. 15, 2001

Other News To Note

Aug. 15, 2001

Xenova Signs #90M Deals With QLT And Genencor International

Aug. 15, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...